Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.59
- Piotroski Score 8.00
- Grade Neutral
- Symbol (USNA)
- Company USANA Health Sciences, Inc.
- Price $40.36
- Changes Percentage (-0.43%)
- Change -$0.18
- Day Low $40.01
- Day High $40.57
- Year High $54.81
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/04/2025
- Fiscal Year End N/A
- Average Stock Price Target $35.00
- High Stock Price Target $35.00
- Low Stock Price Target $35.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.21
- Trailing P/E Ratio 14.79
- Forward P/E Ratio 14.79
- P/E Growth 14.79
- Net Income $63.79 M
Income Statement
Quarterly
Annual
Latest News of USNA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Usana Health Sciences Inc (USNA) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...
Active customer count in China saw a 7% year-over-year increase. Positive feedback from the Las Vegas convention indicates rebuilding trust with sales leaders, with benefits expected in Q4 and Q1. Imp...
By Yahoo! Finance | 2 weeks ago -
Some Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On Capital
To identify a potential multi-bagger stock, look for trends such as increasing return on capital employed (ROCE) and growing capital employed. USANA Health Sciences' ROCE is at 16%, industry average, ...
By Yahoo! Finance | 2 months ago -
Insider Sale: Chief People Officer Paul Jones Sells 6,266 Shares of Usana Health Sciences Inc (USNA)
Paul Jones, Chief People Officer of Usana Health Sciences Inc, sold 6,266 shares at $38.38 each, owning 0 shares now. The health and nutrition company sells directly to consumers. With a market cap of...
By Yahoo! Finance | 2 months ago
